Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bioventus Inc. - Class A Common Stock
(NQ:
BVS
)
13.63
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bioventus Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Bioventus Reports First Quarter Financial Results
May 06, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
April 28, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 07, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
August 04, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
July 30, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
July 29, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Earnings Scheduled For May 6, 2025
↗
May 06, 2025
Via
Benzinga
Examining the Future: Bioventus's Earnings Outlook
↗
May 05, 2025
Via
Benzinga
Gapping stocks in Tuesday's session
↗
March 11, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million
↗
March 11, 2025
Bioventus posted strong Q4 results, with EPS and revenue surpassing estimates. The company projects 2025 sales of $560M–$570M and adjusted EPS of $0.64–$0.68.
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
↗
March 11, 2025
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday
↗
March 11, 2025
Via
Benzinga
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 11, 2025
↗
March 11, 2025
Via
Benzinga
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
February 28, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
January 02, 2025
From
Bioventus, Inc.
Via
GlobeNewswire
Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings
↗
November 05, 2024
Via
Benzinga
Topics
Stocks
S&P 500 Gains 1%; Vimeo Shares Spike Higher
↗
November 05, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
November 05, 2024
Via
Benzinga
Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September
↗
November 05, 2024
Via
Benzinga
Bioventus Reports Third Quarter Financial Results
November 05, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
October 29, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Solventum Stock Earns 81 RS Rating
↗
October 15, 2024
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.
Via
Investor's Business Daily
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
October 01, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Executives Buying W. P. Carey And 2 Other Stocks
↗
August 21, 2024
Via
Benzinga
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
August 07, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q2 2024
↗
August 06, 2024
BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
↗
August 06, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
